Effective uptake of N-acetylglucosamine-conjugated liposomes by cardiomyocytes in vitro

Journal of Controlled Release

Volumn 122, Issue 2, 2007, Pages 189-198

  Aso, Shin ichi ^a   Ise, Hirohiko ^a   Takahashi, Masafumi ^a   Kobayashi, Satoshi ^a   Morimoto, Hajime ^a   Izawa, Atsushi ^a   Goto, Mitsuaki ^b   Ikeda, Uichi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Celagix Res Ltd   (Japan)

Author keywords

Cardiomyocytes; Drug delivery; Lectin; Liposomes; N acetylglucosamine

Indexed keywords

CARDIOLOGY; DISEASES; DRUG DELIVERY; DRUG INTERACTIONS; FLUORESCENCE; NITRIC OXIDE;

ACETYLGLUCOSAMINES; CARDIOMYOCYTES; DRUG DELIVERY SYSTEM (DDS); LECTIN;

LIPOSOMES;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOSOME; N ACETYLGLUCOSAMINE; NITRIC OXIDE; PRAVASTATIN;

ANIMAL CELL; ARTICLE; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; ENCAPSULATION; FLOW CYTOMETRY; FLUORESCENCE; HEART MUSCLE; HEART MUSCLE CELL; HYDROPHILICITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLGLUCOSAMINE; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; ENDOCYTOSIS; ENZYME INDUCTION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERLEUKIN-1BETA; LIPIDS; LIPOSOMES; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PARTICLE SIZE; PRAVASTATIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34548399707     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.07.003     Document Type: Article

References (30)

1. Yamazaki N., Kojima S., Bovin N.V., Andre S., Gabius S., and Gabius H.J. Endogenous lectins as targets for drug delivery. Adv. Drug Deliv. Rev. 43 (2000) 225-244
2. Hatt S.L., Harbottle R.P., Cooper R., Miller A., Williamson R., and Coutelle C. Gene delivery and expression mediated by an integrin-binding peptide. Gene Ther. 2 (1995) 552-554
3. Koning G.A., Schiffelers R.M., Wauben M.H., Kok R.J., Mastrobattista E., Molema G., ten Hagen T.L.M., and Strorm G. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum. 54 (2006) 1198-1208
4. Monsigny M., Roche A.C., Midoux P., and Mayer R. Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes. Adv. Drug Deliv. Rev. 14 (1994) 1-24
5. Nishikawa M. Development of cell-specific targeting system for drugs and genes. Biol. Pharm. Bull. 28 (2005) 195-200
6. Weis W.I., and Drickamer K. Structural basis of lectin-carbohydrate recognition. Annu. Rev. Biochem. 65 (1996) 441-473
7. Roche A.C., Fajac I., Grosse S., Frison N., Rondanino C., Mayer R., and Monsigny M. Glycofection: facilitated gene transfer by cationic glycopolymers. Cell. Mol. Life Sci. 60 2 (2003) 288-297
8. Cook S.E., Park I.K., Kim E.M., Jeong H.J., Park T.G., Choi Y.J., Akaike T., and Cho C.S. Galactosylated polyethylenimine-graft-poly(vinylpyrrolidone) as a hepatocyte-targeting gene carrier. J. Control. Release 105 (2005) 151-163
9. Kobayashi K., and Sumimoto H. Synthesis and functions of polystyrene derivatives having pendent oligosaccharaides. Polym. J. 17 (1985) 567-575
10. Kobayashi K., Sumimoto H., and Ina Y. A carbohydrate-containing synthetic polymer obtained from N-p-vinylbenzyl-d-gluconamid. Polym J. 15 (1983) 667-671
11. Maruyama A., Ishihara T., Adachi N., and Akaike T. Preparation of nanoparticles bearing high density carbohydrate chains using carbohydrate-carrying polymers as emulsifier. Biomaterials 15 (1994) 1035-1042
12. Ishida T., Iden D.L., and Allen T.M. A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett. 460 (1999) 129-133
13. Chiu S.J., Liu S., Perrotti D., Marcucci G., and Lee R.J. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J. Control. Release 112 (2006) 199-207
14. Ikeda U., Shimpo M., Ikeda M., Minota S., and Shimada K. Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. J. Cardiovasc. Pharmacol. 38 (2001) 69-77
15. Ogata Y., Takahashi M., Takeuchi K., Ueno S., Mano H., Ookawara S., Kobayashi E., Ikeda U., and Shimada K. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy. J. Cardiovasc. Pharmacol. 40 (2002) 907-915
16. Higuchi Y., Kawakami S., Oka M., Yabe Y., Yamashita F., and Hashida M. Intravenous administration of mannosylated cationic liposome/NF-κB decoy complexes effectively prevent LPS-induced cytokine production in a murine liver failure model. FEBS Lett. 580 (2006) 3706-3714
17. Takei Y., Maruyama A., Ferdous A., Nishimura Y., Kawano S., Ikejima K., Okumura S., Asayama S., Nogawa M., Hashimot M., Makino Y., Kinoshita M., Watanabe S., Akaike T., Lemasters J.J., and Sato N. Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronan-glycocalyx. FASEB J. 18 (2004) 699-701
18. Wu G.Y., Keegan-Rogers V., Franklin S., Midford S., and Wu C.H. Targeted antagonism of galactosamine toxicity in normal rat hepatocytes in vitro. J. Biol. Chem. 263 (1988) 4719-4723
19. Stockert R.J. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol. Rev. 75 (1995) 591-609
20. Ise H., Sugihara N., Negishi N., Nikaido T., and Akaike T. Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes. Biochem. Biophys. Res. Commun. 285 (2001) 172-182
21. Ise H., Nikaido T., Negishi N., Sugihara N., Suzuki F., Akaike T., and Ikeda U. Effective hepatocyte transplantation using rat hepatocytes with low asialoglycoprotein receptor expression. Am. J. Pathol. 165 (2004) 501-510
22. Terada T., Iwai M., Kawakami S., Yamashita F., and Hashida M. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting. J. Control. Release 111 (2006) 333-342
23. Diaz C., Vargas E., and Gatjens-Boniche O. Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines. Int. J. Pharm. 325 (2006) 108-115
24. Aramaki Y., Lee I., Arima H., Sakamoto T., Magami Y., Yoshimoto T., Moriyasu F., Mizuguchi J., Koyanagi Y., Nikaido T., and Tsuchiya S. Efficient gene transfer to hepatoblastoma cells through asialoglycoprotein receptor and expression under the control of the cyclin A promoter. Biol. Pharm. Bull. 26 (2003) 357-360
25. Misawa R., Ise H., Takahashi M., Morimoto H., Kobayashi E., Miyagawa S., and Ikeda U. Development of liver regenerative therapy using glycoside-modified bone marrow cells. Biochem. Biophys. Res. Commun. 342 (2006) 434-440
26. Chen Y., Deng Y.J., Hao Y.L., Hao A.J., Zhong H.J., and Wang X.M. Uptake of liposomes by cultured cardiomyocytes. Pharmazie 60 (2005) 844-848
27. Chen Y., Deng Y.J., and Hao Y.L. Surface modification of liposomes for cardiomyocytes targeting in vitro. Pharmazie 60 (2005) 238-240
28. Sawa Y., Morishita R., Suzuki K., Kagisaki K., Kaneda Y., Maeda K., Kadoba K., and Matsuda H. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFκB binding site: evidence for a role of NFκB in ischemia-reperfusion injury. Circulation 96 (1997) 280-285
29. Issa M.M., Koping-Hoggard M., Tommeraas K., Varum K.M., Christensen B.E., Strand S.P., and Artursson P. Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo. J. Control. Release 115 (2006) 103-112
30. Yamazaki N., Kojima S., Gabius S., and Gabius H.J. Studies on carbohydrate-binding proteins using liposome-based systems-I. Preparation of neoglycoprotein-conjugated liposomes and the feasibility of their use as drug-targeting devices. Int. J. Biochem. 24 (1992) 99-104